new_0222_0441|TERN|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
new_0222_0441|TERN|1|Terns Pharmaceuticals Inc Total Current Assets (Quarterly) (USD)|Terns Pharmaceuticals Inc Cash and Short Term Investments (Quarterly) (USD)|Terns Pharmaceuticals Inc Inventories (Quarterly) (USD)|Terns Pharmaceuticals Inc Net PP&E (Quarterly) (USD)|Terns Pharmaceuticals Inc Goodwill and Intangibles (Quarterly) (USD)|Terns Pharmaceuticals Inc Total Liabilities (Quarterly) (USD)|Terns Pharmaceuticals Inc Total Current Liabilities (Quarterly) (USD)|Terns Pharmaceuticals Inc Total Long Term Liabilities (Quarterly) (USD)|Terns Pharmaceuticals Inc Total Deposits (Quarterly) (USD)|Terns Pharmaceuticals Inc Book Value (Quarterly) (USD)|Terns Pharmaceuticals Inc Retained Earnings (Quarterly) (USD)|Terns Pharmaceuticals Inc Treasury Stock (Quarterly) (USD)|Terns Pharmaceuticals Inc EV to Revenues|Terns Pharmaceuticals Inc EV to Earnings|Terns Pharmaceuticals Inc EV to Free Cash Flow|Terns Pharmaceuticals Inc EV to Assets (Quarterly)|Terns Pharmaceuticals Inc PS Ratio|Terns Pharmaceuticals Inc PE Ratio|Terns Pharmaceuticals Inc Price to Book Value|Terns Pharmaceuticals Inc PEG Ratio|Terns Pharmaceuticals Inc Debt to Equity Ratio|Terns Pharmaceuticals Inc Dividend Yield|Terns Pharmaceuticals Inc Shareholder Yield (TTM)|Terns Pharmaceuticals Inc Percent of Shares Outstanding Short|Terns Pharmaceuticals Inc Total Receivables (Quarterly) (USD)|Terns Pharmaceuticals Inc Total Payables (Quarterly) (USD)|Terns Pharmaceuticals Inc Total Capital Stock (Quarterly) (USD)|Terns Pharmaceuticals Inc Return on Invested Capital|Terns Pharmaceuticals Inc Quality Ratio Score|Terns Pharmaceuticals Inc Momentum Score|Terns Pharmaceuticals Inc Beta (1Y)|Terns Pharmaceuticals Inc Sustainable Growth Rate (TTM)|Terns Pharmaceuticals Inc Institutional Investor Ownership Percentage|Terns Pharmaceuticals Inc Average Diluted Shares Outstanding (Quarterly)|Terns Pharmaceuticals Inc Total Employees (Annual)|Terns Pharmaceuticals Inc EPS Diluted (Quarterly) (USD)|Terns Pharmaceuticals Inc Shares Outstanding|Terns Pharmaceuticals Inc Repurchase of Capital Stock (Quarterly) (USD)|Terns Pharmaceuticals Inc Ordinary Shares Number (Quarterly)|Terns Pharmaceuticals Inc Payout Ratio|Terns Pharmaceuticals Inc Quick Ratio (Quarterly)|Terns Pharmaceuticals Inc Normalized Diluted EPS (Quarterly) (USD)|Terns Pharmaceuticals Inc Stock Buybacks (Quarterly) (USD)|Terns Pharmaceuticals Inc Effective Tax Rate (TTM)|Terns Pharmaceuticals Inc Return on Equity|Terns Pharmaceuticals Inc Net Income (TTM) (USD)|Terns Pharmaceuticals Inc Revenue (TTM) (USD)|Terns Pharmaceuticals Inc Dividend Per Share (Quarterly) (USD)|Terns Pharmaceuticals Inc Revenue (Quarterly) (USD)|Terns Pharmaceuticals Inc Gross Profit (Quarterly) (USD)|Terns Pharmaceuticals Inc SG&A Expense (Quarterly) (USD)|Terns Pharmaceuticals Inc Pre-Tax Income (Quarterly) (USD)|Terns Pharmaceuticals Inc Net Income (Quarterly) (USD)|Terns Pharmaceuticals Inc Net Interest Income (Quarterly) (USD)|Terns Pharmaceuticals Inc Price (USD)|Terns Pharmaceuticals Inc Total Return Price (USD)|Terns Pharmaceuticals Inc Enterprise Value (USD)|Terns Pharmaceuticals Inc 30-Day Average Daily Volume|Terns Pharmaceuticals Inc 1 Year Price Returns (Daily)||
new_0222_0441|TERN|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
new_0222_0441|TERN|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|yearly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily||
new_0222_0441|TERN|5|121.833333333|121.833333333||121.833333333||121.833333333|121.833333333|121.833333333||121.833333333|121.833333333||||1.44483985765||||1.44262295082|||1.44483985765||15.24|121.833333333|121.833333333|121.833333333|||||||91.375|365|91.375|27.4285714286||121.833333333|||91.375|91.4285714286|91.4||91.4|||||91.375|91.375|91.375|91.375|1.44483985765|1.44483985765|1.44483985765|1.44444444444|1.39285714286||
new_0222_0441|TERN|6|6|6||6||6|6|6||6|6||||281||||244|||281||25|6|6|6|||||||8|1|8|14||6|||8|7|5||5|||||8|8|8|8|281|281|281|252|28||
new_0222_0441|TERN|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
new_0222_0441|TERN|201912|22.224|19.65||0.961||19.697|4.95|14.747||-90.76|-91.862|||||||||||||||1.636|94.967|||||||23.9717||-0.4078|||22.7217|||-0.4078|||||||||2.388|-10.044|-9.775|0.107|||||||
new_0222_0441|TERN|202003||||||||||||||||||||||||||||||||||23.9717||-0.3755||||||-0.3755|||||||||2.179|-9.206|-9.001|0.05|||||||
new_0222_0441|TERN|202006||||||||||||||||||||||||||||||||||23.9717||-0.4041||||||-0.4041|||||||||2.486|-9.845|-9.688|0.002|||||||
new_0222_0441|TERN|202009|15.421|13.756||1.234||42.261|28.023|14.238||-119.815|-121.986|||||||||||||||0.461|94.967|||||||23.9717||-0.477|||22.7217|||-0.477||-0.2563||-39.899|||||3.333|-11.489|-11.435|0.001|||||||
new_0222_0441|TERN|202012|90.869|74.854||1.175||23.698|22.821|0.877||-117.441|-131.915||||-22.7848|||||||||2.874|12.718|0.935|186.033||||||33.0132|22.7217|30|0.034|25.0967||22.7217|||-0.437||-2.0449||-40.053|||||0.998|-9.218|-9.929|0.002|22.65|22.65|692.4993||||
new_0222_0441|TERN|202103|198.042|195.581||1.025||9.239|8.377|0.862||190.002|-145.252||||-9.5995||||2.8995|||||6.113||4.25|0.003|||||||15.16||-0.88|25.0417||25.0417|||-0.88|-136.362|-1.943||-44.389|||||4.561|-13.298|-13.337|0.011|22|22|355.3364|207320.4333||22|17.11
new_0222_0441|TERN|202106|186.872|185.084||0.959||6.675|5.818|0.857||181.332|-155.99||||-3.3343||||1.6991|||||2.4562||1.688|0.003|||||||25.11||-0.43|25.1306||25.1306|||-0.43||-1.9361||-45.439|||||4.857|-10.724|-10.738|0.055|12.26|12.26|123.0172|93864.7||7.5|13.46
new_0222_0441|TERN|202109|178.794|177.196||0.927||7.734|6.893|0.841||172.156|-167.825||||-2.222||||1.5292|||||2.7791||1.582|0.003|||||||25.1483||-0.47|25.2648||25.2648|||-0.47||-1.7401||-45.839|||||4.715|-11.815|-11.835|0.049|10.42|10.42|86.0632|77973.2333||9.5|7.55
new_0222_0441|TERN|202112|166.93|165.982||1.046||7.767|6.82|0.947||160.303|-182.073||||-0.3005|0.0754|||1.1145|||||2.3185||2.126|0.003|||||||25.2957|41|-0.56|25.2693||25.2693||24.3375|-0.56||-1.0232||-50.158|||1||5.416|-13.813|-14.248|0.055|7.07|7.07|12.672|82796.8333|-85.3422|6.27|3.32
new_0222_0441|TERN|202203|||||||||||||||2.0966||||0.4839||||||||||||||||||||||||||||||||||||3.07|3.07|-88.4052|47857.2333|-88.3447||